Behavioral Family Systems Therapy (BFST) for Teens With Type 2 Diabetes (ADAPT)

May 17, 2017 updated by: Lisa Buckloh, PhD, Nemours Children's Clinic

Behavioral Family Systems Therapy for Teens With Type 2 Diabetes: A Pilot

This is a randomized, controlled pilot trial of Behavioral Family Systems Therapy for Teens with Type 2 Diabetes (BFST-DM2), an individual psychological intervention tailored to meet the needs of teens with type 2 diabetes. It is hypothesized that this behavioral family intervention will be feasible to implement with teens with type 2 diabetes and will have positive effects on treatment adherence, health outcomes like weight status and metabolic control, and psychological outcomes.

Study Overview

Detailed Description

The incidence of type 2 diabetes mellitus (DM2) in youth is increasing dramatically with the rise in obesity in the U.S. and worldwide. DM2 in youth, as with adults, is clearly linked to modifiable risk factors such as obesity, sedentary lifestyle, and poor diet. Youth with DM2 are at increased risk for medical complications such as cardiovascular disease, retinopathy, and neuropathy, as well as psychological problems such as depression, anxiety, poor self-esteem, eating disorders, and poor coping and problem solving. Although there are studies demonstrating that family-based lifestyle and psychological interventions are successful in reducing obesity in youth and in improving metabolic control and adherence in youth with type 1 diabetes mellitus (DM1), very little has been published on potential lifestyle or psychological treatments for youth with DM2. Studies have shown that Behavioral Family Systems Therapy (BFST) has been effective in improving metabolic control, adherence, family communication, and problem solving in youth with DM1. This intervention could be effective in treating youth with DM2, as many of the skills necessary for good metabolic control, health outcomes, treatment adherence, and psychological adjustment are similar in both populations. This application proposes a randomized, controlled pilot trial of BFST-DM2, an individual psychological intervention tailored to meet the needs of teens with DM2. BFST will be adapted to make this intervention more feasible and relevant with minority and low-income populations and also to focus on weight management, exercise, and nutrition. The BFST-DM2 intervention includes 12 (90-minute) sessions over 6 months. Areas targeted for improvement will include metabolic control, weight/body mass index, treatment adherence, family lifestyle choices (activity, diet), family communication, and problem solving. One of the main aims of this pilot study is to gather exploratory information on the effectiveness of the BFST-DM2 intervention on measures of health outcomes, medical adherence, lifestyle changes, and family problem-solving and communication skills. In addition, it is an aim to estimate treatment effect size to determine the sample size needed to power a larger multi-site trial of the BFST-DM2 intervention. Other aims include determining factors associated with feasibility (recruitment, retention, participation, generalizability) as well as to modify the intervention to be culturally sensitive and to be more relevant to the individual needs of the DM2 adolescent population. The BFST-DM2 intervention will be compared with standard medical therapy on measures of health outcomes (metabolic control, body mass index, weight, waist circumference, body fat) physical activity (accelerometer), nutritional intake, treatment adherence, psychological adjustment (self-esteem, quality of life), family communication, and problem solving. The researchers will analyze predictors of treatment outcome and the treatment effects at the immediate post-treatment interval (6 months from baseline). Health outcomes and medical adherence data also will be collected 12 months from baseline to determine maintenance of treatment effects over time.

Study Type

Interventional

Enrollment (Actual)

24

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Jacksonville, Florida, United States, 32207
        • Nemours Children's Specialty Care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

11 years to 17 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosed with type 2 diabetes mellitus for 6 months or more
  • Age-adjusted Body Mass Index at or above the 85th percentile (considered overweight)
  • Established diabetes care in Nemours Children's Clinic system or diabetes care meets minimum criteria for current American Diabetes Association Standards.
  • Adolescent lives at home in the study geographical area (Jacksonville, FL)over the course of the study duration (one year).
  • One caregiver in the home is willing to participate in the family intervention.

Exclusion Criteria:

  • Adolescent has another systemic chronic disease other than well-controlled asthma.
  • Genetic syndrome or disorder (other than diabetes) known to affect glucose tolerance.
  • Daily use of glucocorticoids or other medications known to affect glucose tolerance.
  • Teen is enrolled in special education for students who have autism or are mentally handicapped.
  • Adolescent is pregnant or planning to be pregnant within 1 year.
  • Teen resides in temporary foster care, group home, or juvenile detention center.
  • The family has an open case with an agency investigating child abuse or neglect.
  • Adolescent has been in an inpatient psychiatric facility or substance abuse treatment in the past 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BFST for Teens with Type 2 Diabetes
Psychological intervention: Families randomized to the intervention group will receive 12 sessions of Behavioral Family Systems Therapy for Teens with type 2 diabetes (BFST-DM2) over 6 months.
BFST for Teens with Type 2 Diabetes: 12 (90 minute sessions) over 6 months of Behavioral Family Systems Therapy (BFST), delivered by a Licensed clinical social worker. BFST consists of 4 components: problem-solving, communication skills training, cognitive restructuring, and functional and structural family therapy.
Other Names:
  • BFST - Behavioral Family Systems Therapy
No Intervention: Control group (Standard Care)
The participants assigned to the control group will receive their standard medical care for diabetes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body Mass Index (weight status) at 6 months and at 12 months
Time Frame: baseline, 6 months after baseline, 12 months after baseline
Body Mass Index (adjusted for height, gender, and age) - height and weight in kg and meters (kg/m^2) - change in BMI across time points is being studied - change in weight from baseline to 6 months and change in weight from baseline to 12 months
baseline, 6 months after baseline, 12 months after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment Adherence
Time Frame: baseline, 6 months after baseline, 12 months after baseline
Treatment Adherence is measured using the Diabetes Self Management Survey for Teens with Type 2 Diabetes.
baseline, 6 months after baseline, 12 months after baseline
Physical activity
Time Frame: baseline, 6 months after baseline
Physical activity is measured by an accelerometer
baseline, 6 months after baseline
Teen Self-esteem
Time Frame: baseline, 6 months after baseline
Teen Self-Perception/Self-esteem is measured by the Harter Self-Perception Profile
baseline, 6 months after baseline
Teen Quality of Life
Time Frame: baseline, 6 months after baseline
Teen Quality of Life is measured by The Pediatric Quality of Life Inventory (PedsQL)
baseline, 6 months after baseline
metabolic control (HbA1c)
Time Frame: baseline, 6 months after baseline, 12 months after baseline
Metabolic control is measured using HbA1c values
baseline, 6 months after baseline, 12 months after baseline
Family Problem-solving
Time Frame: baseline, 6 month after baseline
Family problem-solving is measured using the Revised Diabetes Family Conflict Scale
baseline, 6 month after baseline
Body Fat (weight status)
Time Frame: baseline, 6 months after baseline, 12 months after baseline
Body fat percent change - measured by a hand-held body fat impedance device
baseline, 6 months after baseline, 12 months after baseline
Waist Circumference (weight status)
Time Frame: baseline, 6 months after baseline, 12 months after baseline
Waist circumference in cm
baseline, 6 months after baseline, 12 months after baseline
Food intake
Time Frame: baseline, 6 months after baseline
Nutrition/food intake as measured by the Nutrition Data Systems for Research interview
baseline, 6 months after baseline
Family communication skills
Time Frame: baseline, 6 months after baseline
Family communication skills are measured by the Family Communication (Interaction Behavior Code)
baseline, 6 months after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2011

Primary Completion (Actual)

July 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

October 6, 2015

First Submitted That Met QC Criteria

May 17, 2017

First Posted (Actual)

May 18, 2017

Study Record Updates

Last Update Posted (Actual)

May 18, 2017

Last Update Submitted That Met QC Criteria

May 17, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on BFST for Teens with Type 2 Diabetes

3
Subscribe